Conference abstract · 20 Jul 2015
Conference abstractPublished 18 Aug 2015
HCV cost effectiveness model
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hepatitis C is thought to infect 3-5 million Americans, frequently resulting in cirrhosis and related diseases. The treatment up until recently had been based on interferon and ribaviron with efficacy rates of under 40% for most patients, much lower on an intention to treat basis. Several new oral anti-viral treatments have been developed and approved, now with efficacy rates of 90-99%. Treatment costs have been controversial with per pill prices set at $1,000-$1,125. We set out to examine the cost effectiveness of these new treatments.Life expectancy is estimated to improve 15 years in patients cured with early disease; this is reduced in patients with advanced disease. The model incorporates the observation of log-rhythmic increase in mortality as cirrhosis occurs. The HCV Medical Treatment Model predicts a cost of $6,467 per year of life saved for patients treated with no cirrhosis. The same model calculates a cost $160,500 per year of life saved for patients with advanced cirrhosis. The current benchmark of cost per year of hemodialysis is $72,000-89,000. The model suggests patients with early HCV disease are cost effective to treat with the most current medical treatment regimens, but not so for patients with cirrhosis.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Mar 2015
TT-034: A single injection provides safe and durable hepatic expression of anti-HCV shRNAs in a non-human primate model
Research article · 8 Jan 2020
Indirect diagnosis of HCV viremia in Malian women: Relevance of a Cost-effective Algorithm
Conference abstract
Is it cost effective to pool donations for nucleic acid testing for HCV screening in blood banks from high prevalence communities?
Commentary · 28 Feb 2023
Phylogenetic Analysis of Acute and Chronic Sequences and Mathematical Models of Early HCV Diversification
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Research article · 1 Jan 2026
Prospective Observational Study for the Evaluation of Efficacy and Safety Profile of Probiotics Food Supplement in Children with Acute Diarrhea
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Howard M Hack”
